These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19879831)

  • 21. BST-2 diminishes HIV-1 infectivity.
    Zhang J; Liang C
    J Virol; 2010 Dec; 84(23):12336-43. PubMed ID: 20861258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
    Neil SJ; Zang T; Bieniasz PD
    Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetherin and its viral antagonists.
    Kuhl BD; Cheng V; Wainberg MA; Liang C
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):188-201. PubMed ID: 21222046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
    Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
    J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.
    Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV
    J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetherin: holding on and letting go.
    Sauter D; Specht A; Kirchhoff F
    Cell; 2010 Apr; 141(3):392-8. PubMed ID: 20434978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
    Jia B; Serra-Moreno R; Neidermyer W; Rahmberg A; Mackey J; Fofana IB; Johnson WE; Westmoreland S; Evans DT
    PLoS Pathog; 2009 May; 5(5):e1000429. PubMed ID: 19436700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.
    McNatt MW; Zang T; Hatziioannou T; Bartlett M; Fofana IB; Johnson WE; Neil SJ; Bieniasz PD
    PLoS Pathog; 2009 Feb; 5(2):e1000300. PubMed ID: 19214216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetherin/BST-2: Restriction Factor or Immunomodulator?
    Li SX; Barrett BS; Guo K; Santiago ML
    Curr HIV Res; 2016; 14(3):235-46. PubMed ID: 26957198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network.
    Dubé M; Roy BB; Guiot-Guillain P; Mercier J; Binette J; Leung G; Cohen EA
    J Virol; 2009 May; 83(9):4574-90. PubMed ID: 19244337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimerization of the transmembrane domain of human tetherin in membrane mimetic environments.
    Cole G; Simonetti K; Ademi I; Sharpe S
    Biochemistry; 2012 Jun; 51(25):5033-40. PubMed ID: 22667354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin.
    Lv M; Wang J; Zhu Y; Wang X; Zuo T; Liu D; Zhang J; Wu J; Zhang H; Kong W; Yu X
    FEBS Lett; 2013 Jan; 587(1):37-43. PubMed ID: 23201263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses.
    Sakuma T; Sakurai A; Yasuda J
    PLoS One; 2009 Sep; 4(9):e6934. PubMed ID: 19742323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
    Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetherin Inhibits Cell-Free Virus Dissemination and Retards Murine Leukemia Virus Pathogenesis.
    Liberatore RA; Mastrocola EJ; Powell C; Bieniasz PD
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetherin restricts HSV-2 release and is counteracted by multiple viral glycoproteins.
    Liu Y; Luo S; He S; Zhang M; Wang P; Li C; Huang W; Hu B; Griffin GE; Shattock RJ; Hu Q
    Virology; 2015 Jan; 475():96-109. PubMed ID: 25462350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin.
    Kluge SF; Mack K; Iyer SS; Pujol FM; Heigele A; Learn GH; Usmani SM; Sauter D; Joas S; Hotter D; Bibollet-Ruche F; Plenderleith LJ; Peeters M; Geyer M; Sharp PM; Fackler OT; Hahn BH; Kirchhoff F
    Cell Host Microbe; 2014 Nov; 16(5):639-50. PubMed ID: 25525794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression.
    Dotson D; Woodruff EA; Villalta F; Dong X
    J Biol Chem; 2016 Feb; 291(8):4236-46. PubMed ID: 26742839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain.
    Hinz A; Miguet N; Natrajan G; Usami Y; Yamanaka H; Renesto P; Hartlieb B; McCarthy AA; Simorre JP; Göttlinger H; Weissenhorn W
    Cell Host Microbe; 2010 Apr; 7(4):314-323. PubMed ID: 20399176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.